DXd, has been approved in the US for the treatment of adult patients with unresectable or metastatic hormone receptor HR-positive, HER2-negative breast cancer who have received prior endocrine-based ...

AstraZeneca said the U.S. Food and Drug Administration approved Datroway, a treatment for metastatic breast cancer developed in combination with Daiichi Sankyo.

Two new studies have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer.

Two new studies led by researchers at Washington University School of Medicine in St. Louis have identified a possible way to block the progression of several forms of blood cancer using a drug ...

Researchers at the National University of Singapore (NUS) have developed a non-invasive method to improve the effectiveness of chemotherapy while reducing its harmful side effects.

A Comprehensive Review of Epidemiology, Risk Factors, and Treatment Strategies. Advances in Breast Cancer Research, 14, 1-15. doi: 10.4236/abcr.2025.141001 . Noncommunicable diseases like various ...

At 12-year follow-up, C9741 confirmed the sustained long-term benefit of adjuvant dose-dense chemotherapy for node-positive breast cancer. SET2,3 identified patients with ER+ breast cancer who ...

Triple-negative breast cancer or TNBC is a subtype of breast cancer in which the cancer cells test negative for estrogen, progesterone, and HER2 receptors. Treatment options for triple-negative breast ...

The Food and Drug Administration (FDA) has just approved Novartis’ Kisqali (ribociclib) in combination with an aromatase inhibitor as treatment for people with HR+/HER2- stage II and III early breast ...

Department of Bioengineering, University of Pennsylvania, 210 S. 33rd Street, 435 Skirkanich Hall, Philadelphia, Pennsylvania 19104, United States ...

When breast cancer becomes stage 4 (metastatic), it is no longer curable but is still very treatable. Treatment options for metastatic breast cancer include chemotherapy, targeted therapy, ...

In the introduction to their paper, the researchers detail how research in acute myeloid leukemia, breast ... cancer therapies. This innovative approach marks a paradigm shift in cancer treatment.